Big business: Doctors and pharmaceutical companies
News | 22 January 2013
Those payments range from speaking engagements to research and education. According to ProPublica, an independent non-profit research newsroom geared to investigative journalism, more than $220 million was spent by large pharmaceutical companies ...
Click on the link to read the full article at KVIA El Paso
(This link will open in a new window)
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
